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Abstract 
The molecular and cellular mechanisms underlying vascular remodeling are currently investigated 
several experimental strategies which aim to mimic the complex environmental conditions found in 
vivo. Some of them focus on the tubulogenic activity of dispersed endothelial cell populations, 
while others evaluate vascular sprouting. Here we propose a new method to assess matrigel 
invasion starting from confluent or subconfluent monolayers of human microvascular ECs 
(HMVEC) seeded on different substrates. The experimental setting is also validated by an improved 
hybrid multiscale mathematical approach, which integrates a mesoscopic grid-based cellular Potts 
model, that describes HMVEC phenomenology, with a continuous one, accounting for the kinetics 
of diffusing growth factors. Both experimental and theoretical approaches show that the endothelial 
potential to invade, migrate and organize in tubule structures is a function of selected environmental 
parameters. The present methodology is intended to be simple to use, standardized for rapid 
screening and suitable for mechanistic studies.  
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Introduction 
Blood vessel formation is a multiscale event that can occur through different mechanisms, 
including vasculogenesis and sprouting angiogenesis. The overall process is largely mediated by the 
redundant activity of soluble and fixed environmental factors, respectively including growth factors, 
such as VEGFs and FGF, and extracellular matrix (ECM) components, such as collagen, fibronectin 
and gelatin (Munaron 2006; Dister et al., 2003; Munaron et al., 2000). In particular, the dynamic 
interactions between microvascular endothelial cells (EC) and ECM proteins are mediated by 
integrins, a superfamily of cell surface receptors whose selective recruitment regulates the 
angiogenic process. In more details, the complex αvβ3 has been identified as a marker of 
angiogenesis (Brook et al., 2015). 
Vascular remodeling occurs during development as well as in adult life; however, it can also 
become pathological, as in the cases of chronic inflammatory diseases, vasculopathies, degenerative 
disorders, ischemia-associated tissue injury and cancer. Moreover, the control of neovascularization 
is of great interest in the field of tissue engineering, in order to increase biocompatibility and 
reabsorption of biomaterials to be employed for a great number of clinical applications (Ahsan et 
al., 2005; Yarlagadda et al., 2005; Carmeliet 2000). For these reasons, the establishment of easy to 
use, statistically robust and hopefully high throughput experimental protocols, which can be readily 
suitable to evaluate the angiogenic potential in vitro by the use of EC cultures, is increasingly 
required.  
In this respect, some approaches, such as the ‘scratch wound healing’ and transwell-based methods, 
are mainly focused on EC migration, one of the events required for angiogenesis. On the other 
hand, other assays that resemble the formation of tubules are regarded as representative of the later 
stages of angiogenesis (differentiation) and are extensively used to test novel compounds for their 
pro- or anti-angiogenic activity (Kleinman et al., 1986). In particular, to perform the ‘endothelial 
tube formation assay’ (or ‘tubulogenesis assay’), EC are initially plated as a dispersed population in 
a tridimensional matrix, usually Matrigel or similar substrates, which favors cell migration and 
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differentiation in the virtual absence of cell proliferation (Benton et al., 2014). Beside its 
oversimplification, and the lack of a true lumen formation, this experimental protocol revealed very 
suitable and useful to investigate the molecular mechanisms underlying angiogenic regulation, as 
shown by the great amount of related publications. However, this approach does not account for 
sprouting angiogenesis often occurring during neovascularization. During this event EC move from 
a confluent compact monolayer (the preexisting vessel) to the ECM, that they invade and digest, 
and eventually organize in tubule structures. Current strategies focused on endothelial sprouting 
involve tridimensional spheroids of cancer cell-EC co-cultures and aortic ring assays (Benton et al., 
2014). Alternative techniques allow to realistically reproduce morphologic steps and molecular 
events controlling human capillary tube and lumen formation in three-dimensional extracellular 
matrices (Davis et al., 2000; Koh et al., 2008; Vailhè et al., 2001; Saunders et al., 2006).  
However, as far as we know, no experimental protocol has successfully assessed the tubulogenic 
activity of pure microvascular endothelial populations starting from bidimensional monolayers 
coated on controlled substrates. This condition is optimal for the formation of interconnected 
tubules that mimic the in vivo blood vasculature in a highly simplified system in which tubule 
development is observed over a 4-24 hrs time span. This issue is addressed here by an easy-to-use 
novel Ibidi-based set up, suitable to quantitatively assess in vitro endothelial sprouting in highly 
controlled conditions. Selected features of the experimental setting are also reproduced and 
validated by a proper cellular Potts model-based computational approach.  
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Materials and Methods 
Cell culture 
Human microvascular endothelial cell line (HMVEC) was purchased from Lonza (Switzerland), 
grown in Endothelial Cell Growth Medium (EGM-MV-VEGF) (Lonza, Switzerland) and 
maintained at 37°C in a humidified atmosphere of 5% CO2.  
 
Cell culture medium and extracellular matrix 
Endothelial Cell Growth Medium (EGM-MV-VEGF) (Lonza, Switzerland) is optimized for the 
culture of human microvascular endothelial cells; it contains 5% of serum and VEGF for rapid 
proliferation. EGM-MV-VEGF used in this work contains the following components: 5 ng/ml  rh 
VEGF, 5 ng/ml rh EGF, 5ng/ml rh FGF basic, 15 ng/ml rh IGF-1, 10 mM L-Glutamine, 1.0 µg/ml 
Hydrocortisone Hemisuccinate, 0.75 U/ml Heparin Sulfate, 50 µg/ml Ascorbic Acid.  
Dulbecco′s Modified Eagle′s Medium (DMEM) (Sigma-Aldrich) is a complete liquid form of the 
high glucose modification of Dulbecco's original formulation that contains four-fold concentrations 
of the amino acids and vitamins. The DMEM high glucose medium, used in this work, differs from 
the original formula, because it is, also, supplemented with L-alanyl-L-glutamine dipeptide, 10% of 
serum and 10 mM L-Glutamine. Gelatin Solution (Sigma-Aldrich). Gelatin Type B, 2% in H2O, is a 
heterogeneous mixture of water-soluble proteins of high average molecular masses, present in 
collagen. Proteins are extracted by boiling the relevant skin, tendons, ligaments, bones, etc. in 
water. Type B is derived from lime-cured tissue. This product was use as a cell culture substratum 
at 1-5 µg/cm2 or 0.5-50 µg/mL. 
 
Matrigel (BD Matrigel Membrane Matrix Growth Factor Reduced-GFR). BD Bioscences is suited 
for applications where a more highly defined basement membrane preparation is desired. Its major 
component is laminin, followed by collagen IV, heparan sulfate proteoglycans, entactin/nidogen. 
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Matrigel contains also TGF-beta, epidermal growth factor, insulin-like growth factor, fibroblast 
growth factor, tissue plasminogen activator, and other growth factors (Vukicevic et al., 1992; 
McGuire et al., 1989, see Table 1). 
 
Endothelial tube formation assay (ETFA). 
To assess invasion and angiogenic activity Ibidi culture-inserts (Ibidi, Martinsried, Germany) were 
employed. The Ibidi culture-Insert is a manufactured from biocompatible silicone material. Cell 
suspension can be placed in one or both wells allowing to grow cells in the designated areas only 
(see Table 2). The delimited central area of each well was then coated with Matrigel GFR 
previously polymerized for 30 min at 37°C, see Fig. 1. In our experiments, Matrigel coating 
simulated extracellular matrix (ECM); Matrigel, indeed, contained not only basement membrane 
components (collagens, laminin, and proteoglycans) but also matrix degrading enzymes, their 
inhibitors and growth factors. Subconfluent (10 x 104 cells/well) or confluent (20 x 104 cells/well) 
HMVECs (SC-HMVECs and C-HMVECs, respectively) were plated in the outer region of each 
well (i.e., the area without Matrigel coating, see Fig. 1). After 18hrs, the Ibidi device was removed 
from each well. The subsequent HMVEC invasion, migration and network formation within the 
Matrigel coated central area were then periodically observed by phase-contrast microscopy using 
10x objective magnification (Olympus IX50, equipped with a Cool SNAP-Pro charge-coupled 
device (CCD) camera), until 72hrs. The	time-lapse	representative	images	of	the	computational	assay	 show	 different	 stages	 of	 migration,	 invasion	 and	 capillary-like	 network	 formation.	
Experimental images were then processed using ImageJ (National Institutes of Health, NIH, US) 
software.  
 
Quantification of HMVEC invasion and tubulogenic activity 
Endothelial tube formation was analyzed by the use of Angiogenesis Analyzer plugin of ImageJ 
software. This tool allows to easily quantify the ETFA experiment images by extracting 
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characteristic information of the network it allow the network analysis organization of individual 
ECs images taken in phase contrast or in fluorescence. Tubulogenic potential is expressed as a set 
of parameters including the total tube length (µm) and the total number of junctions.  
 
Viability assay 
SC-HMVECs were seeded in the outer region of each well. After 72hrs cell viability was evaluated 
by the CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay (Promega, Madison, WI, 
USA), using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H 
tetrazolium, inner salt (MTS). MTS conversion into the aqueous soluble formazan product is 
accomplished by dehydrogenase enzymes found in metabolically active cells. Formazan product 
was measured with a FilterMax F5 Microplate reader (Molecular Devices, US) at 490 nm, as 
absorbance is directly proportional to the number of viable cells.  
 
Statistics  
Statistical significance of all experiments was evaluated by Kaleidagraph software (Synergy 
Software, USA) using nonparametric Wilcoxon test. The Wilcoxon test was used for cell 
tubulogenesis analysis because the percentages of tubulogenesis were not normally distributed. All 
values are presented as the mean ± standard error (SE). For each experimental condition (C-
HMVEC, SC-HMVEC both grown in DMEM 10% or EGM-MV-VEGF) five technical replicates 
were performed; three biological replicates were done for each experiment: N=3. Results with p-
values < 0.05 were considered statistically significant.  
 
Mathematical model 
The experimental assay was reproduced with a hybrid multilevel approach, able to span the multiple 
scales underlying HMVEC invasion and tubule organization. In particular, at the cellular level, an 
extended version of the cellular Potts Model (CPM), a lattice-based Monte Carlo technique which 
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follows an energy minimization principle, was the core of the simulation system and described the 
phenomenology of HMVEC population, capturing the mechanisms of cell migration, polarization, 
adhesion, and proliferation. At the molecular level, a continuous model reproduced instead the 
kinetics and the morphogenic activity of chemical growth factors, dealing with their production, 
diffusion and degradation. The two submodels were then interfaced and integrated in order to link 
the behavior of cells to their biochemical state.  In this respect, the multicellular invasion across the 
matrix, and the subsequent network formation, emerged as a consequence of cellular and 
subcellular dynamics. The statistical analysis of the model outcomes was performed by MatLab 
(The MathWorks Inc., US) procedures, specifically encoded for this work. In particular, coherently 
with the experimental protocol, we focused on network determinants such as the total tubule 
length/area and the number of junctions. All values are presented as the mean ± standard error (SE) 
over 50 independent simulations. For a detailed description of the mathematical approach see the 
Supplementary Information.  
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Results 
The experimental assay described in this work was set up to measure the ability of a human 
microvascular endothelial monolayer to invade the matrix and self-organize in capillary-like 
networks (Fig. 1). In particular, to study the collective cell dynamics involved in the overall 
process, we considered HMVEC in different experimental growth conditions, that differed for three 
environmental parameters critically involved in neovascularization: cell-cell contact (confluent or 
subconfluent monolayers), growth factor enrichment (DMEM 10% or EGM-MV-VEGF medium), 
and cell adhesion to the substrate (presence or absence of gelatin). 
When grown in both EGM-MV-VEGF or in DMEM 10% media and plated in the absence of any 
coating substrate, SC-HMVEC started invading the Matrigel with a typical ‘wound healing-like’ 
behavior (Fig. 2A). In both cases, after nearly 18 hrs, the cells starting from the front of the 
monolayer drafted to organize in tubule structures. Later (72 hrs), an extended area of Matrigel was 
covered by tubule structures: in particular the total vessel length and total number of junctions were 
highly dependent on the growth factor enrichment of the medium, being drastically more 
pronounced in  EGM-MV-VEGF than in DMEM 10% (Fig. 2A-B). The same phenomenology, with 
very similar dynamics, was captured by the computational approach (Fig. 3A-B), although the 
resulting patterns were characterized (in average) by longer branches and fewer junctions.  
Interestingly, the invasive behavior of SC-HMVECs growing on gelatin-coated substrate drastically 
differed depending on the medium (Fig. 2D). In particular, HMVEC grown in EGM-MV-VEGF 
displayed limited Matrigel invasion without tubule organization (Fig. 2D1), although cell viability 
was unaltered (Supplementary Fig.1, panel A). The already poor tubulogenic potential of HMVEC 
cultured in DMEM 10% medium was instead not significantly affected by gelatin coating, in terms 
of both total vessel length and total number of junctions (Fig. 2D2). The mathematical approach 
substantially confirmed these data (Fig. 3A-B).  
C-HMVEC resulted viable only when grown in EGM-MV-VEGF, while the viability in DMEM 
10% was too low (less than 46%) to allow any suitable and statistically robust experiments. C-
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HMVEC grown in EGM-MV-VEGF were initially closely packed each other (24 hrs). As a 
consequence, in an early phase they invaded Matrigel in a ‘wound healing-like’ fashion more 
prominently than SC-HMVEC: a leading front of the population advanced in fact more significantly 
and compactly across the Matrigel (Fig. 2C1). Conversely, in later phase (72 hrs) the tubulogenic 
potential of C-HMVEC appeared drastically reduced if compared to SC-HMVEC, in terms of both 
total vessel length and total number of junctions (Fig. 2A-F). The corresponding sets of 
mathematical simulations captured the same behavior (Fig. 3A-C); in particular, the emerging in 
silico tubule structures were more poorly extended and typically formed by shorter and thicker 
branches.   
Similarly to the case of SC-HMVECs, the tubulogenic potential of C-HMVEC grown in EGM-MV-
VEGF was further drastically prevented when the monolayer was plated on a gelatin-coated 
substrate (Fig. 2D3-E). These evidences were nicely reproduced by mathematical simulations as 
well (Fig. 3A-C). 
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Discussion 
Here we present a novel assay which aims to provide an in vitro experimental tool to investigate the 
role of environmental parameters on the formation of endothelial tubule network starting from a 
simple monolayer of cells growing on a selected adhesion substrate.  
The experimental evidence was further validated with a proper theoretical framework. In particular, 
the proposed mathematical approach is firmly anchored in the computational literature, as it is 
essentially based on a series of Cellular Potts Models dealing with different scenarios of vascular 
progression. However, when compared to the previous published works, it presents some relevant 
novelties, which were introduced to better reproduce the specific experimental conditions. 
A preliminary consideration concerns the relevance of culture medium. Both in vitro and in silico 
evidences clearly indicate that the maximal morphogenic potential can be observed in HMVEC 
grown in EGM-MV-VEGF, a medium enriched with proangiogenic factors, while tubulogenesis is 
significantly reduced in DMEM 10%  (Figs. 2 and 3). This observation is expected according to the 
conventional tubulogenesis assays described in literature for micro and macrovascular endothelium 
(Benton et al., 2014). 
On the other hand, the role played by cell confluence is not trivial. HMVEC starting from 
monolayer at sub-confluence density show an enhanced ability to form mature tubule networks 
when compared with confluent populations. This evidence suggests that the cell density of the 
monolayer is inversely proportional to the tubulogenic potential. Interestingly, this correlation is 
unlikely to be due to an overall decrement in cell migration expected for the enhanced cell-cell 
interactions at confluence: the initial ‘wound-like’ compact invasion of Matrigel at 24 hours is in 
fact more prominent starting from C-HMVEC than from SC-HMVEC. The increment in the 
intercellular adhesive interactions (consequent to the higher cell density) partially disrupts the 
regulation of the chemotactic component of cell migration, which is required for a proper 
networking behavior. This mechanism, called ‘contact inhibition of chemotaxis’, has been widely 
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recognized and described in the experimental and computational literature (Hellstrom et al., 2007; 
Lin et al., 2015; Scianna et al., 2015).  
In this respect, our method will be well employed for future investigations aimed to shed light on 
this particular issue: indeed, differently from other approaches, it is suitable for time lapse 
fluorescence microscopy imaging, aimed at measuring the dynamics of intracellular messengers 
critically involved in endothelial migration and organization in tubule networks. Among them, 
calcium signaling calcium-related machinery have been widely recognized as key mediators of 
specific steps occurring during angiogenic events (Munaron, 2012). In particular, previous reports 
from our group established a correlation between tubulogenic potential and calcium signals in pato-
physiological conditions (Fiorio Pla et al., 2008; Munaron, 2012). 
From the computational point of view, calcium dynamics should be approached with continuous 
methods (i.e., reaction-diffusion equations) based on experimental data mainly obtained from 
electrophysiological and fluorimetric measurements. In particular, the impact of cell confluence on 
the calcium machinery could be accounted in the reaction term of the corresponding equation. Such 
new mathematical ingredients should be then interfaced with the lattice-based CPM, as previously 
shown by our group in previous reports (Scianna et al., 2011; Munaron et al., 2012).   
In particular, the resulting mathematical approach will be able to systematically characterize the 
relationship between intracellular calcium dynamics, cell confluence and the resulting pattern. For 
instance, a promising study could be focused on the modeling counterparts of biomedical strategies 
that have the potential to disrupt network formation, in the case of pathological situations. This way, 
it would be possible not only to confirm the efficacy of some currently available anti-angiogenic 
therapies but also to suggest novel and experimentally testable treatments. Since the interaction with 
the substrate is critical for endothelial cell adhesion, migration, signaling and angiogenic potential 
(Muhammad et al., 2007; Shen et al., 2011; Neve et al, 2014), we decided to compare endothelial 
remodeling starting from cell monolayers plated with or without gelatin, widely used to enhance 
cell attachment. We show that gelatin completely prevents tubulogenesis of both C-HMVEC and 
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SC-HMVEC cultured in EGM-MV-VEGF, but not in DMEM 10% (Fig. 2). These data suggest that 
the proangiogenic potential of factors contained in EGM-MV-VEGF (mainly VEGF and FGF) 
could be at least partially prevented by gelatin, leading to a relevant anti-tubulogenic effect. This 
activity is substantially independent on cell confluence and, thus, on the previously-cited physical 
constraints related to cell-cell contact (see Fig. 2). We can exclude a significant contribution of 
putative increased mitogenic potential in EGM-MV-VEGF/gelatin condition, that could eventually 
reduce migration and differentiation, since gelatin coating does not affect HMVEC proliferation 
induced by EGM-MV-VEGF (Supplementary Fig.1 panel A). Our results with gelatin-coating are in 
nice agreement with several reports showing that differences in the degree of cell-ECM adhesion 
could promote distinct endothelial cell behaviors important for angiogenesis (Neve et al., 2014). 
Gelatin is largely used to enhance endothelial spreading and adhesion on its substrate and these 
events regulate the expression of genes associated with angiogenesis. In particular, VEGF-related 
signaling and gene expression result highly sensitive to cell adhesion: among the genes most highly 
upregulated in un-spread cells in the presence of VEGF are those included in the microarrays of 
angiogenesis that involve endothelial invasion, migration and organization (VEGF and 
Angiopoietin receptors, MMP14 and some integrins) (Shen et al, 2011; Bell et al., 2001; Gerritsen 
et al., 2002). Taken together, these (and other) observations suggest that limiting cell adhesion 
through multiple mechanisms, whether via changes in ligand density or cell spreading, induced the 
expression of genes associated with the invasive processes of angiogenesis. Further mechanistic 
studies should deserve attention on this topic, and the method described in this paper could usefully 
contribute. The present Ibidi-based assay does not aim at substituting the well-established and 
powerful alternative techniques already used to study the endothelial remodeling in vitro. 
Nevertheless, it may provide easy to use and standardized additional information on the 
mechanisms underlying the morphogenic behavior of vascular endothelium.  
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Figure legends 
Figure 1: Experimental setup (see Methods). In each well an Ibidi insert delimited the outer cell 
culture area and the central Matrigel coated area (see the white dashed lines in the experimental 
panels). After removing the Ibidi barrier, HMVEC were allowed to invade and migrate within the 
central Matrigel coated region until 72 hrs (see the corresponding white dashed lines in the 
experimental panels). The computational domain was setup to closely resemble the in vitro 
configuration (refer also to Supplementary Fig.1). 
 
Figure 2: Experimental evaluation of HMVEC invasion and pseudo-capillary network formation.  
A-D. Representative images from HMVEC cultured in different conditions described in the results. 
A. Initial ‘wound-like’ phase of Matrigel invasion by subconfluent (SC) HMVEC grown in DMEM 
10% FCS (1) or in EGM-MV-VEGF (2) (12 hrs). 
B. Late Matrigel invasion (72 hrs) of HMVEC plated at subconfluence (SC) in DMEM 10% FCS 
(1) or in EGM-MV-VEGF (2). Images in 1’ and 2’ are representative fields taken for tubulogenesis 
analysis and images in 1” and 2” are an example of the graphical output generated by Angiogenesis 
Analyzer (see Methods).  
C. Early and late Matrigel invasion of HMVEC grown at confluence  in EGM-MV-VEGF. Image in 
1’ is representative for the early 'wound-like' migration and images 2' and 2” show tubulogenesis at 
72 hrs. In particular, image in 2” is an example of the graphical output generated by Angiogenesis 
Analyzer (see Methods). 
D. Late Matrigel invasion (72 hrs) of HMVEC grown at subconfluence (SC) or confluence (C) in 
DMEM 10% FCS or in EGM-MV-VEGF and plated on gelatin-coated substrate. Image in 2’ is a 
representative field taken for tubulogenesis analysis and image 2” is an example of the graphical 
output generated by Angiogenesis Analyzer (see Methods). In A-D, the black lines indicate the 
position of the Ibidi, delimiting the initial cell plated area from the Matrigel coated region. 
E. Plot showing the statistics of  tubule length in the experimental conditions of A-D (72 hrs).  
F. Plot showing the statistics of total number of junctions in the experimental conditions of A-D.  
In E-F, the values in the plots are given as mean±standard error (SE) (n=3 independent 
experiments). 
 
Figure 3. Computational evaluation of HMVEC invasion and pseudo-capillary network formation.  
A. Representative simulation images from HMVEC cultured in the different conditions described in 
the results at the final observation time (72 hrs).  
B. Plots showing the statistics of tubule length (µm).  
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C. Plots showing the statistics of the total number of junctions corresponding to the experimental 
conditions of A.  
Values are given as mean±standard error (SE) out of over 50 independent simulations. 
 
